ICON Public Limited Company




Biotechnology & Medical Research

Real-time Estimate Cboe BZX 12:54:21 2024-02-21 pm EST 5-day change 1st Jan Change
283.6 USD +0.03% Intraday chart for ICON Public Limited Company -2.85% +0.47%
This article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
The fate of the market depends on this Our Logo
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever.... Our Logo
Barclays Adjusts Price Target on ICON to $325 From $280, Maintains Overweight Rating MT
Transcript : ICON Public Limited Company Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 05:15 PM
ICON Public Limited Company Provides Earnings Guidance for the Full Year 2023 and 2024 CI
Slow start for Wall Street Our Logo
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom... Our Logo
Truist Securities Starts Coverage on ICON with Buy Rating, $357 Price Target MT
Powell is getting ready to crush investors 'hopes Our Logo
ANALYST RECOMMENDATIONS : Adobe, AMD, Apple, Costco, HP, Snap... Our Logo
Citigroup Adjusts ICON Price Target to $315 From $300, Maintains Buy Rating MT
Let's party like it's 2021 Our Logo
ANALYST RECOMMENDATIONS : Adobe, Broadcom, Comcast, Fair Isaac, Salesforce... Our Logo
Deutsche Bank Raises ICON Price Target to $320 From $295, Maintains Buy Rating MT
Data keeps fueling the momentum Our Logo
ANALYST RECOMMENDATIONS : Blackrock, Costco, Dollar Tree, Duke Energy, Snowflake... Our Logo
Transcript : ICON Public Limited Company Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-29-2023 12:30 PM
Transcript : ICON Public Limited Company Presents at 14th Annual Jefferies London Healthcare Conference 2023, Nov-14-2023 02:00 PM
All good things must come to an end Our Logo
ANALYST RECOMMENDATIONS : Best Buy, Diageo, Eli Lilly, Estee Lauder, Home Depot... Our Logo
ICON Seeks Acquisitions CI
Transcript : ICON Public Limited Company, Q3 2023 Earnings Call, Oct 26, 2023
ICON Q3 Adjusted EPS, Revenue Rise; Full-Year Guidance Disclosed MT
Earnings Flash (ICLR) ICON Posts Q3 EPS $3.30, vs. Street Est of $3.28 MT
Earnings Flash (ICLR) ICON Posts Q3 Revenue $2.06B, vs. Street Est of $2.06B MT
Chart ICON Public Limited Company
More charts
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors. Its sectors include Biosimilars, Biotech, Government and public health solutions, medical devices, pharmaceuticals and the IVDR journey.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Mean consensus
Number of Analysts
Last Close Price
283.5 USD
Average target price
305.9 USD
Spread / Average Target
  1. Stock
  2. Equities
  3. Stock ICON Public Limited Company - Nasdaq
  4. News ICON Public Limited Company
  5. Deutsche Bank Raises ICON Price Target to $320 From $295, Maintains Buy Rating
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance